Effect of 6R-BH4 Treatment in Coronary Artery Disease (OXBIO Study)

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. Identifier: NCT00423280
Recruitment Status : Unknown
Verified June 2008 by University of Oxford.
Recruitment status was:  Recruiting
First Posted : January 18, 2007
Last Update Posted : August 7, 2008
BioMarin Pharmaceutical
Information provided by:
University of Oxford